160 related articles for article (PubMed ID: 28659833)
1. Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson's Disease with Comorbid Depression versus Patients with Major Depressive Disorder.
Svenningsson P; Pålhagen S; Mathé AA
Front Psychiatry; 2017; 8():102. PubMed ID: 28659833
[TBL] [Abstract][Full Text] [Related]
2. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
Hou C; Jia F; Liu Y; Li L
Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
[TBL] [Abstract][Full Text] [Related]
3. Elevated cerebrospinal fluid 5-hydroxyindoleacetic acid levels in women with comorbid depression and panic disorder.
Sullivan GM; Oquendo MA; Huang YY; Mann JJ
Int J Neuropsychopharmacol; 2006 Oct; 9(5):547-56. PubMed ID: 16259647
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid neuropeptide Y levels in major depression and reported childhood trauma.
Soleimani L; Oquendo MA; Sullivan GM; Mathé AA; Mann JJ
Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539507
[TBL] [Abstract][Full Text] [Related]
5. Effects of maternal separation on neuropeptide Y and calcitonin gene-related peptide in "depressed" Flinders Sensitive Line rats: a study of gene-environment interactions.
Wörtwein G; Husum H; Andersson W; Bolwig TG; Mathé AA
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):684-93. PubMed ID: 16600456
[TBL] [Abstract][Full Text] [Related]
6. Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson's disease are associated with nonmotor symptoms.
Tong Q; Zhang L; Yuan Y; Jiang S; Zhang R; Xu Q; Ding J; Li D; Zhou X; Zhang K
Parkinsonism Relat Disord; 2015 Aug; 21(8):882-7. PubMed ID: 26028271
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y in PTSD, MDD, and chronic stress: A systematic review and meta-analysis.
Tural U; Iosifescu DV
J Neurosci Res; 2020 May; 98(5):950-963. PubMed ID: 32048334
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptides and electroconvulsive treatment.
Mathé AA
J ECT; 1999 Mar; 15(1):60-75. PubMed ID: 10189619
[TBL] [Abstract][Full Text] [Related]
9. Impact of Depression on Hospitalization and Related Outcomes for Parkinson's Disease Patients: A Nationwide Inpatient Sample-Based Retrospective Study.
Patel RS; Makani R; Mansuri Z; Patel U; Desai R; Chopra A
Cureus; 2017 Sep; 9(9):e1648. PubMed ID: 29142796
[TBL] [Abstract][Full Text] [Related]
10. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.
Heilig M; Zachrisson O; Thorsell A; Ehnvall A; Mottagui-Tabar S; Sjögren M; Asberg M; Ekman R; Wahlestedt C; Agren H
J Psychiatr Res; 2004; 38(2):113-21. PubMed ID: 14757324
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y and calcitonin gene-related peptide: effects on glucagon and insulin secretion in the mouse.
Pettersson M; Lundquist I; Ahrén B
Endocr Res; 1987; 13(4):407-17. PubMed ID: 3329090
[TBL] [Abstract][Full Text] [Related]
12. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.
Yoon HS; Hattori K; Sasayama D; Kunugi H
J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339
[TBL] [Abstract][Full Text] [Related]
13. Relationships of Cerebrospinal Fluid Monoamine Metabolite Levels With Clinical Variables in Major Depressive Disorder.
Yoon HS; Hattori K; Ogawa S; Sasayama D; Ota M; Teraishi T; Kunugi H
J Clin Psychiatry; 2017; 78(8):e947-e956. PubMed ID: 28749090
[TBL] [Abstract][Full Text] [Related]
14. Depression Reduces Accuracy While Parkinsonism Slows Response Time for Processing Positive Feedback in Patients with Parkinson's Disease with Comorbid Major Depressive Disorder Tested on a Probabilistic Category-Learning Task.
Herzallah MM; Khdour HY; Taha AB; Elmashala AM; Mousa HN; Taha MB; Ghanim Z; Sehwail MM; Misk AJ; Balsdon T; Moustafa AA; Myers CE; Gluck MA
Front Psychiatry; 2017; 8():84. PubMed ID: 28659830
[TBL] [Abstract][Full Text] [Related]
15. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
Dumont Y; Chabot JG; Quirion R
Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
[TBL] [Abstract][Full Text] [Related]
16. Patterns of neuronal colocalisation of tyrosine hydroxylase, neuropeptide Y, vasoactive intestinal polypeptide, calcitonin gene-related peptide and substance P in human ureter.
Edyvane KA; Smet PJ; Trussell DC; Jonavicius J; Marshall VR
J Auton Nerv Syst; 1994 Aug; 48(3):241-55. PubMed ID: 7525686
[TBL] [Abstract][Full Text] [Related]
17. Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain.
Franco-Cereceda A; Saria A; Lundberg JM
Acta Physiol Scand; 1989 Feb; 135(2):173-87. PubMed ID: 2784250
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Ogawa S; Tsuchimine S; Kunugi H
J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
[TBL] [Abstract][Full Text] [Related]
19. Alterations in perivascular dilatory neuropeptides (CGRP, SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man.
Juul R; Hara H; Gisvold SE; Brubakk AO; Fredriksen TA; Waldemar G; Schmidt JF; Ekman R; Edvinsson L
Acta Neurochir (Wien); 1995; 132(1-3):32-41. PubMed ID: 7538726
[TBL] [Abstract][Full Text] [Related]
20. Salivary 5-hydroxyindole acetic acid (5-HIAA) in drug-naïve patients with short-illness-duration first episode major depressive disorder.
Cubala WJ; Landowski J; Chrzanowska A
Neuro Endocrinol Lett; 2014; 35(8):746-9. PubMed ID: 25702305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
